Text Size
1245 studies found for:    alzheimer

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Unknown † Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Biological: Clinic and neuropsychologic evaluation;   Radiation: MRI;   Procedure: PET;   Biological: Apolipoprotein E genotyping;   Biological: Study of cerebrospinal fluid
22 Completed
Has Results 		A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Interferon beta-1a;   Drug: Placebo
23 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease;   Dementia
Intervention:
24 Completed Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 0.1 mg/kg;   Biological: PF-04360365 0.5 mg/kg;   Biological: PF-04360365 1 mg/kg;   Drug: Placebo;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 8.5 mg/kg
25 Completed Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
26 Completed Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
Condition: Alzheimer's Disease
Intervention:
27 Completed
Has Results 		Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
Condition: Alzheimer Disease
Interventions: Drug: Rivastigmine 5 cm^2;   Drug: Rivastigmine 10 cm^2;   Drug: Rivastigmine 15 cm^2;   Drug: Placebo to 15 cm^2 patch;   Drug: Placebo to 10 cm^2 patch
28 Unknown † Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
29 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
30 Completed Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
31 Completed Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases;   Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
32 Completed Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Condition: Alzheimer Disease
Intervention:
33 Completed
Has Results 		Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine transdermal patch;   Drug: Placebo
34 Completed A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Other: MRI;   Other: FDG-PET
35 Active, not recruiting Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Memory Loss;   Cognitive Impairment
Intervention: Drug: ladostigil hemitartrate
36 Not yet recruiting Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: AADvac1
37 Completed
Has Results 		ELND005 in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Placebo Control;   Drug: ELND005
38 Completed Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: atomoxetine hydrochloride;   Drug: placebo
39 Completed Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: placebo
40 Completed Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy
Condition: Alzheimer Disease
Intervention: Other: observational
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years